User account menu Search Menu Novartis Financial Data Product Sales Full Year 2020 Product Sales The following table provides the top 20 Innovative Medicines Division product net sales in 2020 as well as the change compared to 2019: Brands Net Sales (USD m) % change (USD) Business Franchise Cosentyx 3,995 13% Immunology, Hepatology and Dermatology Gilenya 3,003 -7% Neuroscience Entresto 2,497 45% Cardiovascular, Renal and Metabolism Tasigna 1,958 4% Oncology Lucentis 1,933 -7% Ophthalmology Promacta/Revolade 1,738 23% Oncology Tafinlar + Mekinist 1,542 15% Oncology Sandostatin 1,439 -9% Oncology Jakavi 1,339 20% Oncology Xolair1 1,251 7% Respiratory Galvus Group 1,199 -8% Established Medicines Gleevec/Glivec 1,188 -6% Oncology Afinitor/Votubia 1,083 -30% Oncology Diovan Group 1,003 -6% Established Medicines Exforge Group 980 -4% Established Medicines Zolgensma 920 155% Neuroscience Ilaris 873 30% Immunology, Hepatology and Dermatology Kisqali 687 43% Oncology Exjade/Jadenu 653 -33% Oncology Votrient 635 -16% Oncology Net sales reflect Xolair sales for all indications. Related Links Product recalls Product and patient safety training Novartis production and manufacturing B-roll (Video) Novartis key multiple sclerosis product Gilenya® approved in China Novartis Navigate Topics Explore Companies Footer Bottom © 2021 Novartis AG Terms of Use Privacy Contacts Cookie Settings Site Map Novartis Site Directory This site is intended for a global audience Your privacy is important for us. We use cookies to enhance your experience when visiting our websites: performance cookies show us how you use this website, functional cookies remember your preferences and targeting cookies help us to share content relevant to you. Select “Accept all” for giving your consent to all cookies, select “Cookie settings” for managing the different cookies or select “Reject all” for using only strictly necessary cookies. You can change your cookie settings at any point of time by pressing the cookie settings link on the website. Cookie Settings Reject all Accept all